Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Materials Science & Engineering. C, Materials for Biological Applications
|
April 4, 2021
Multifunctional mats by antimicrobial nanoparticles decoration for bioinspired smart wound dressing solutions
J Avossa, G Pota, G Vitiello, et al.
Beneficial Microbes
|
November 27, 2020
Characterisation of EFV12 a bio-active small peptide produced by the human intestinal isolate <i>Lactobacillus gasseri</i> SF1109
M Di Napoli, B Di Luccia, G Vitiello, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 13, 2018
Trabectedin in Ovarian Cancer: is it now a Standard of Care?
J Ventriglia, I Paciolla, S C Cecere, et al.
Gynecologic Oncology
|
January 18, 2017
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin
A Bergamini, C Pisano, M Di Napoli, et al.
European Review for Medical and Pharmacological Sciences
|
July 30, 2013
Intravesical chemo-immunotherapy in non muscle invasive bladder cancer
D Leopardo, S C Cecere, M Di Napoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
D Lorusso, G Scambia, S Pignata, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
C D'Alterio, G Rea, M Napolitano, et al.
Scientific Reports
|
September 4, 2015
Monomeric C-reactive protein--a key molecule driving development of Alzheimer's disease associated with brain ischaemia?
M Slevin, S Matou, Y Zeinolabediny, et al.
ESMO Open
|
April 25, 2025
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial
G Schepisi, M Urbini, C Casadei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
M C Piccirillo, G Scambia, A Bologna, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Materials Science & Engineering. C, Materials for Biological Applications
|
April 4, 2021
Multifunctional mats by antimicrobial nanoparticles decoration for bioinspired smart wound dressing solutions
J Avossa, G Pota, G Vitiello, et al.
Beneficial Microbes
|
November 27, 2020
Characterisation of EFV12 a bio-active small peptide produced by the human intestinal isolate <i>Lactobacillus gasseri</i> SF1109
M Di Napoli, B Di Luccia, G Vitiello, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 13, 2018
Trabectedin in Ovarian Cancer: is it now a Standard of Care?
J Ventriglia, I Paciolla, S C Cecere, et al.
Gynecologic Oncology
|
January 18, 2017
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin
A Bergamini, C Pisano, M Di Napoli, et al.
European Review for Medical and Pharmacological Sciences
|
July 30, 2013
Intravesical chemo-immunotherapy in non muscle invasive bladder cancer
D Leopardo, S C Cecere, M Di Napoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
D Lorusso, G Scambia, S Pignata, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
C D'Alterio, G Rea, M Napolitano, et al.
Scientific Reports
|
September 4, 2015
Monomeric C-reactive protein--a key molecule driving development of Alzheimer's disease associated with brain ischaemia?
M Slevin, S Matou, Y Zeinolabediny, et al.
ESMO Open
|
April 25, 2025
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial
G Schepisi, M Urbini, C Casadei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
M C Piccirillo, G Scambia, A Bologna, et al.
Page
of 3